Sale of 4,166 shares at $55.0663 per share.
Reporting Person Krempa David · Officer Title Chief Business Officer · Transaction Code S
Traded Oct 6, 2026 · Disclosed Oct 6, 2026
Source: SEC Form 4 · 0001437749-26-032240 · filed 2026-10-06 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Eton Pharmaceuticals, Inc. (ETON)." Disclosed 2026-10-06. https://desqlong.com/cards/0001437749-26-032240-2 (retrieved 2026-10-07).